2nd International China BioPharmaceutical Symposium
نویسندگان
چکیده
منابع مشابه
2nd International Symposium on Triglycerides and HDL
Lipoprotein subclasses Robert S. Rosenson (Chicago IL) discussed lipoprotein subclasses, inflammation, and cardiovascular disease (CVD) risk in the metabolic syndrome. Insulin resistance impairs VLDL particle clearance, leading to greater interchange of core triglyceride from VLDL with LDL and HDL, with LDL and HDL triglyceride enrichment leading both to become substrates for hepatic lipase, re...
متن کامل2nd International Symposium on TURBULENCE, HEAT AND MASS TRANSFER
Generation of vortices enhances heat transfer by swirl, flow destabilization and development of viscous layers. They may increase heat transfer by several hundred percent. Prior to the use of vortices to influence heat transfer it must be known how different vortices are generated and controlled, and how they interact with the base flow and temperature field. To select the most appropriate vort...
متن کامل2nd International Symposium on triglycerides and HDL: metabolic syndrome.
This is the first of two articles summarizing the 2nd International Symposium on Triglycerides and HDL, organized by the Giovanni Lorenzini Medical Foundation and held in New York, New York, 14–17 July 2005. Anthony Gotto (New York, NY) gave an overview of the “evolving story” of HDL and triglycerides in cardiovascular disease (CVD) prevention. He noted that statins only reduce clinical events ...
متن کامل2nd Pakistan international biennial conference on Ramadan and health
The ninth month of Islamic calendar is known as Ramadan, in which fasting is obligatory for every adult man and woman, except in certain health conditions and during travelling. Since Islamic jurisprudence follows the lunar calendar, which is about 11 days shorter than the Gregorian, Ramadan falls in different seasons throughout the year. The duration of fasting hence may differ by 11 to 18 hou...
متن کاملJuvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.
Juvenile myelomonocytic leukemia (JMML) is an aggressive childhood myeloproliferative disorder characterized by the overproduction of myelomonocytic cells. JMML incidence approaches 1.2/million persons in the United States (Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995). Although rare, JMML is innately informative as the molecular genetics of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Clinical Pharmacology
سال: 2009
ISSN: 1751-2433,1751-2441
DOI: 10.1586/17512433.2.2.169